Patient‐Specific Modelling in Drug Design, Development and Selection Including its Role in Clinical Decision‐Making

N Shublaq, C Sansom… - Chemical Biology & Drug …, 2013 - Wiley Online Library
Genomics has made enormous progress in the twelve years since the publication of the first
draft human genome sequence, but it has not yet been translated into the clinic. Despite …

[PDF][PDF] Modeling and informatics in drug design

PV Bharatam, S Khanna, SM Francis - … handbook: ADME and …, 2008 - academia.edu
Modeling and informatics in drug design Page 19 1 1 MODELING AND INFORMATICS IN DRUG
DESIGN Prasad V. Bharatam,* Smriti Khanna, and Sandrea M. Francis National Institute of …

Molecular modelling

X Barril, R Soliva - Molecular BioSystems, 2006 - pubs.rsc.org
The enormous pressure that the pharmaceutical and biotech companies are facing, has
created the need to apply all available techniques to decrease attrition rates, costs and the …

From base pair to bedside: molecular simulation and the translation of genomics to personalized medicine

DW Wright, S Wan, N Shublaq… - … Systems Biology and …, 2012 - Wiley Online Library
Despite the promises made that genomic sequencing would transform therapy by
introducing a new era of personalized medicine, relatively few tangible breakthroughs have …

Applying computational modeling to drug discovery and development

N Kumar, BS Hendriks, KA Janes, D de Graaf… - Drug discovery today, 2006 - Elsevier
Computational models of cells, tissues and organisms are necessary for increased
understanding of biological systems. In particular, modeling approaches will be crucial for …

Predictive software for drug design and development: recent progress and future developments

RC Jackson - Pharmaceutical Development and Regulation, 2003 - Springer
The drug discovery and development process has become more quantitative and much
more computationally intensive in recent years. For pharmaceutical and biotechnology …

[HTML][HTML] Looking beyond the cancer cell for effective drug combinations

JR Dry, M Yang, J Saez-Rodriguez - Genome medicine, 2016 - Springer
Combinations of therapies are being actively pursued to expand therapeutic options and
deal with cancer's pervasive resistance to treatment. Research efforts to discover effective …

[HTML][HTML] How to find the right drug for each patient? Advances and challenges in pharmacogenomics

A Kalamara, L Tobalina, J Saez-Rodriguez - Current opinion in systems …, 2018 - Elsevier
Cancer is a highly heterogeneous disease with complex underlying biology. For these
reasons, effective cancer treatment is still a challenge. Nowadays, it is clear that a cancer …

[HTML][HTML] Multiscale modelling of drug mechanism and safety

JD Zhang, L Sach-Peltason, C Kramer, K Wang… - Drug discovery today, 2020 - Elsevier
Highlights•We introduce models at molecular, cellular and omics, and organ and system
levels.•Models share mathematics as the language and informatics as a tool to study …

PREDICT: a method for inferring novel drug indications with application to personalized medicine

A Gottlieb, GY Stein, E Ruppin… - Molecular systems biology, 2011 - embopress.org
Inferring potential drug indications, for either novel or approved drugs, is a key step in drug
development. Previous computational methods in this domain have focused on either drug …